Alkeran, Phelinun (melphalan) is a small molecule pharmaceutical. Melphalan was first approved as Alkeran on 1982-01-01. It is used to treat breast neoplasms, multiple myeloma, neuroblastoma, ovarian neoplasms, and rhabdomyosarcoma in the USA. It has been approved in Europe to treat hematopoietic stem cell transplantation, hodgkin disease, multiple myeloma, myeloid leukemia acute, and neuroblastoma amongst others.
|Indication||breast neoplasms, hematopoietic stem cell transplantation, hodgkin disease, multiple myeloma, myeloid leukemia acute, neuroblastoma, non-hodgkin lymphoma, ovarian neoplasms, precursor cell lymphoblastic leukemia-lymphoma, rhabdomyosarcoma|